ENOV
ENOV
NYSE · Health Care

Enovis Corp

$26.52
-0.73 (-2.68%)
As of May 10, 10:09 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.56B
Net Income
-1,346,194,481
Gross Margin
58.2%
Profit Margin
-52.7%
Rev Growth
+12.9%
D/E Ratio
0.87
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 58.2% 58.2% 66.5% 66.5%
Operating Margin -50.1% -45.1% 9.3% 10.1%
Profit Margin -52.7% -50.1% 7.8% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.56B 2.26B 959.49M 1.06B
Gross Profit 1.49B 1.32B 638.34M 705.58M
Operating Income -1,279,824,466 -1,020,412,844 89.71M 107.61M
Net Income -1,346,194,481 -1,073,330,114 74.78M 72.61M
Gross Margin 58.2% 58.2% 66.5% 66.5%
Operating Margin -50.1% -45.1% 9.3% 10.1%
Profit Margin -52.7% -50.1% 7.8% 6.9%
Rev Growth +12.9% +12.9% -5.1% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 352.27M 352.27M 570.05M 575.91M
Total Equity 404.67M 404.67M 642.51M 611.09M
D/E Ratio 0.87 0.87 0.89 0.94
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -871,118,144 -733,134,511 123.09M 130.61M
Free Cash Flow 63.08M 92.88M